SMARCA4-Deficient Undifferentiated Tumor of the Right Colon in a Patient With Ulcerative Colitis.
OA: gold
CC-BY-4.0
Abstract
Undifferentiated gastrointestinal tumors with SMARCA4 deficiency are a rare subset of malignancies that often present as advanced, rapidly progressive disease. SMARCA4 loss is identified by immunohistochemistry, and affected tumors demonstrate distinct morphological features. Ulcerative colitis is a chronic inflammatory disorder that predisposes patients to colitis-associated colorectal cancer through a variety of genetic alterations. We present the case of a 31-year-old patient with a SMARCA4-deficient undifferentiated right-sided colon cancer detected during surveillance colonoscopy for ulcerative colitis. We also review the potential association between ulcerative colitis and SMARCA4-deficient undifferentiated gastrointestinal tumors.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
SciLite annotations
chemicals 13
deoxyribonucleic acid
tocilizumab
tocilizumab
corticosteroid
5-fluorouracil
picolinic acid
oxaliplatin
5-fluorouracil
5-fluorouracil
picolinic acid
irinotecan
oxaliplatin
pembrolizumab
organisms 1
human
Source provenance
- europepmc
- last seen: 2026-09-13T09:25:22.628771+00:00
- scilite
- last seen: 2026-09-13T09:58:29.948030+00:00
License: CC-BY-4.0
· commercial use OK
· attribution required
Per Europe PMC
Per Europe PMC